ANI Pharmaceuticals
ANI Pharmaceuticals
Agent31Agent Readiness: 31/100. Below median. Measured by StartupHub.ai. Median 41.Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.
About
ANI Pharmaceuticals is a diversified biopharmaceutical company that develops, manufactures, and commercializes therapeutics. Their strategic focus is on transforming into a leading Rare Disease company, while also maintaining a Generics and Established Brands business. They offer a range of prescription pharmaceutical products.
Key facts
At-a-glance profile data
- Website
- anipharmaceuticals.com
- Headquarters
- Baudette, United States
- Founded
- 1996
- Employees
- 707
- Total funding
- $671M (Acquisition)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 24 Jun 2024 | Acquisition | $381M | Blackstone, J.P. Morgan Asset Management |
| 12 May 2023 | Public Offering | $75M | Guggenheim Partners, Truist Securities, Inc. |
| 1 Nov 2021 | Acquisition | $90M | - |
| 10 Mar 2014 | Private Placement/Follow on | $125M | - |
Tech stack
Detected on anipharmaceuticals.com, last scanned 17 Sept 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- Analytics
- Google Analytics 4
- Cookie consent
- Osano
Add first review
Frequently asked
How much funding has ANI Pharmaceuticals raised?
ANI Pharmaceuticals has raised a total of $671M in funding. The most recent round on record is Acquisition.
How many employees does ANI Pharmaceuticals have?
ANI Pharmaceuticals has approximately 707 people on record.